“To ensure patients equal access to diagnostics and new drugs, regional oncological networks must become a reality, to allow patients to be treated in an organizational mechanism that combines structures, professionalism and technology, in order to improve their survival”. Thus Stefania Gori, president of the Aiom Foundation and of the Italian Oncology Patient Network (Ropi), intervened underlining the importance of regional oncological networks during the online meeting “New strategies for the fight against lung cancer”, promoted by The European House Ambrosetti with the non-conditioning contribution of Amgen. “Two recent studies – explained the expert – show that breast cancer survival is higher if the woman is operated on in a center with a high frequency of activity, and that mortality is reduced if it is followed by a multidisciplinary group. just as a US study has shown that the survival of those suffering from head and neck cancer is better if there is quick access to radiotherapy. “” It is important to understand that in addition to drugs, the value of organizations is very important – concluded Gori – and it must be said that the situation has improved in recent years, protocols and guidelines have been defined in 15 regions, but there is still a lot to do, the networks must ensure the careful selection of patients using all methods available up to the Ngs tests “which allow a simultaneous evaluation of dozens of genetic alterations on non-small cell lung cancers,” which represent the avant-garde.